Our Western blot analysis revealed significantly reduced levels of NRF2 and HO1 in both cortex and hippocampus in Aβ1 − 42-injected animals; surprisingly, Trolox treatment significantly enhanced the expression of NRF2/HO1 in the AD-induced mice brain (Figure 6A). Here, NFE2L2 is linked to Alzheimer disease.